SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-012422
Filing Date
2021-05-21
Accepted
2021-05-21 08:30:17
Documents
3
Period of Report
2021-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 55601
2 ex10-1.htm EX-10.1 79538
3 ex10-2.htm EX-10.2 75665
  Complete submission text file 0001493152-21-012422.txt   212198
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 21946654
SIC: 2834 Pharmaceutical Preparations